Special Educational Needs: support in England
An overview of the current system of support for children and young people with special educational needs, and pressure on the system
On 20 October 2016, the Government announced a new funding settlement for contractors providing NHS pharmaceutical services under the community pharmacy contractual framework. Compared to 2015/16 levels, the funding settlement includes a reduction of 4% in 2016/17 and a further 3.4% in 2017/18. This briefing includes constituency data on pharmacies, including a list of those expected to be eligible for the Pharmacy Access Scheme. There will be an Opposition Day debate on community pharmacies on Wednesday 2 November 2016 in the Commons chamber.
Community Pharmacies (296 KB , PDF)
NHS England is responsible for commissioning all NHS primary care services in England, including community pharmacy services. Clinical commissioning groups (CCGs) are free to commission further services from community pharmacies over and above those commissioned by NHS England, and local authorities are able to commission public health services from pharmacies.The large majority of NHS income for community pharmacies in England comes from payment from NHS England, through the NHS pharmaceutical services contract. The NHS England funding settlement for 2014/15 and 2015/16 was £2.8 billion.
On 20 October 2016 the Government announced that contractors providing NHS pharmaceutical services under the community pharmacy contractual framework will receive:
This represents a 4% reduction in funding in 2016/17 and a further 3.4% reduction in 2017/18.
The announcement also confirmed plans for some additional funding, including:
The downloadable data file below includes a list of pharmacies in each English parliamentary constituency, along with a summary of which are expected to be eligible for the pharmacy access scheme.
For MPs and their staff, Library researchers can provide maps of pharmacies by local area like the one featured below. Please get in touch to find out more.
Community Pharmacies (296 KB , PDF)
An overview of the current system of support for children and young people with special educational needs, and pressure on the system
A briefing on the licensing, regulation and supply of new weight loss medications in England.
A debate has been scheduled in Westminster Hall for 3pm on 23 January on innovation in the field of rare retinal disease. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.